Researchers have developed a new tool to help clinicians tailor personalized treatment plans for patients with a rare blood cancer called chronic myelomonocytic leukemia (CMML). The tool, called the international CMML Prognostic ...
Apr 9, 2026
0
5
Encouraging early results from a SAHMRI-led clinical trial offer new hope to people diagnosed with chronic myelomonocytic leukemia (CMML), a rare and aggressive form of blood cancer.
Jul 31, 2025
0
24
Researchers at Hackensack Meridian's John Theurer Cancer Center (JTCC), are part of a published Phase 3 study reporting on the equivalent safety and effectiveness in the oral treatment of blood cancers–such as myelodysplastic ...
Jan 31, 2024
0
39
A review of a Montana nuclear missile base where an unusual number of troops have been diagnosed with blood cancer has found no current risk factors that could explain it, the Air Force says.
May 2, 2023
0
23
